Healthcare Johnson & Johnson tops 1Q expectations on broad sales bump Updated : April 17, 2018 05:28 PM IST The New Brunswick, New Jersey, company reported net income of $4.37 billion, or $1.60 per share, down from $4.42 billion, or $1.81 per share, in 2017's first quarter. Marketing and production costs were higher partly because of the launch of its new severe psoriasis drug, Tremfya, approved last summer. The world's biggest maker of health care products reported that overseas sales jumped 20%, buoyed by favorable currency exchange rates. Subscribe to Moneycontrol PRO at just Rs.33/- per month for the first year. Use code SUPERPRO. Limited period offer. Available on Web and Android.